The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(7-Benzyl-4-imino-5,6-diphenyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-3-yl)ethyl)pyridin-4-amine ID: ALA5208351
PubChem CID: 50985828
Max Phase: Preclinical
Molecular Formula: C32H28N6
Molecular Weight: 496.62
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N=c1c2c(-c3ccccc3)c(-c3ccccc3)n(Cc3ccccc3)c2ncn1CCNc1ccncc1
Standard InChI: InChI=1S/C32H28N6/c33-31-29-28(25-12-6-2-7-13-25)30(26-14-8-3-9-15-26)38(22-24-10-4-1-5-11-24)32(29)36-23-37(31)21-20-35-27-16-18-34-19-17-27/h1-19,23,33H,20-22H2,(H,34,35)
Standard InChI Key: HYEIDZYLIOTLFQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 43 0 0 0 0 0 0 0 0999 V2000
-1.8714 0.5976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1569 1.0101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4425 0.5976 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4425 -0.2276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2721 -0.6402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.9868 -0.2276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7715 -0.4826 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9851 -1.2795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4017 -1.8628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6015 -1.6484 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0218 -2.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2357 -3.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0329 -3.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6150 -2.6599 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2567 0.1849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0817 0.1849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4959 -0.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3205 -0.5326 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7296 0.1839 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3169 0.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4944 0.8985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7716 0.8525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9852 1.6494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7855 1.8639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9943 2.6616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4126 3.2409 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6155 3.0273 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4019 2.2330 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9868 0.5976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2721 1.0102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2721 1.8352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.5859 1.0101 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.3004 0.5976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3004 -0.2274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0133 -0.6380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.7296 -0.2254 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.7296 0.5954 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0179 1.0119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 9 2 0
15 7 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 16 2 0
22 15 2 0
22 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 23 2 0
29 22 1 0
6 29 2 0
29 30 1 0
3 30 1 0
30 31 2 0
1 32 1 0
32 33 1 0
34 33 2 0
35 34 1 0
36 35 2 0
37 36 1 0
38 37 2 0
33 38 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 496.62Molecular Weight (Monoisotopic): 496.2375AlogP: 6.21#Rotatable Bonds: 8Polar Surface Area: 71.52Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.96CX LogP: 5.50CX LogD: 3.63Aromatic Rings: 6Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -0.96
References 1. Frankowski KJ, Patnaik S, Wang C, Southall N, Dutta D, De S, Li D, Dextras C, Lin YH, Bryant-Connah M, Davis D, Wang F, Wachsmuth LM, Shah P, Williams J, Kabir M, Zhu E, Baljinnyam B, Wang A, Xu X, Norton J, Ferrer M, Titus S, Simeonov A, Zheng W, Mathews Griner LA, Jadhav A, Aubé J, Henderson MJ, Rudloff U, Schoenen FJ, Huang S, Marugan JJ.. (2022) Discovery and Optimization of Pyrrolopyrimidine Derivatives as Selective Disruptors of the Perinucleolar Compartment, a Marker of Tumor Progression toward Metastasis., 65 (12.0): [PMID:35696646 ] [10.1021/acs.jmedchem.2c00204 ]